ADVERTISEMENT
ADVERTISEMENT

immunology

Woman with her back to camera, with arms stretched out, soaking up the sunshine
A Genetic Predisposition to Vitamin D Deficiency Contributes to Severe COVID-19
Iris Kulbatski, PhD | Jun 1, 2023 | 3 min read
Ana Teresa Freitas discussed how individual variation in vitamin D synthesis and metabolism influences susceptibility to upper respiratory viruses.
Illustration of a virus
Vaccines: Sex Matters
Niki Spahich, PhD | Jun 1, 2023 | 3 min read
Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.
An abstract rendering of laboratory flasks with green and pink glowing liquid and scientific shapes floating above.
Traditional Techniques, New Applications
The Scientist’s Creative Services Team | 1 min read
Researchers harness the power of familiar methods to advance science. 
SARS-CoV-2 self-assembling virus-like nanoparticle with spike proteins protruding from the surface.
New Technology Improves SARS-CoV-2 mRNA Vaccine-Induced Immune Responses
Elina Kadriu | May 30, 2023 | 3 min read
mRNA-encoded self-assembling enveloped virus-like particles presenting SARS-CoV-2 spike protein enhance immunity and may provide better protection against viral variants. 
3D rendered illustration of a coronavirus with an overlaid network of lines and dots.
Connecting the Dots That Link Diabetes and Infection Severity
Deanna MacNeil, PhD | May 22, 2023 | 4 min read
Researchers shed light on the immunometabolism of respiratory infection, providing an avenue towards safer COVID-19 therapeutics for those affected by metabolic disorders.
Sun
Relevant Models Reflect Real-World Needs
The Scientist’s Creative Services Team | 1 min read
Jie Sun shares how his curiosity, creativity, and motivation to address clinical public health needs steer his research in immunology and infectious disease.
Scientist pipetting at the bench in white coat and purple gloves
Chek-Mate for Gliomas
Aparna Nathan, PhD | May 22, 2023 | 3 min read
New research may make immunotherapy possible for hard-to-treat brain tumors.
Editing genome stock photo
Resolving Discrepancies in Mouse and Human Autoimmunity Studies
Niki Spahich, PhD | May 15, 2023 | 4 min read
By editing primary T cells with CRISPR, researchers begin to settle a long-standing debate about a common autoimmunity risk variant.
Understanding Hybridoma Technology for Monoclonal Antibody Production
Understanding Hybridoma Technology for Monoclonal Antibody Production
Alpana Mohta, MD | 5 min read
By fusing antibody-producing cells with immortal myeloma cells, researchers produce reliable supplies of highly specific antibodies.
One hand holding the other, depicting pain in the joints
A Bacterial Culprit for Rheumatoid Arthritis
Hannah Thomasy, PhD, Drug Discovery News | Apr 27, 2023 | 4 min read
Scientists identified a species of Subdoligranulum that may drive disease.
Engineered T cells attacking a cancer cell
Helping Engineered T Cells Find Their Way to Tumors
Nele Haelterman, PhD | Apr 18, 2023 | 3 min read
Susan Thomas discusses how her team engineered a microfluidic device to screen for T cells with improved homing capability to tumor cells. 
<em >The Scientist</em>&rsquo;s Journal Club: Immunology
The Scientist’s Journal Club: Immunology
The Scientist’s Creative Services Team | 1 min read
Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.
A doctor checking a patient&rsquo;s blood sugar levels using a glucometer on their ring finger.
An Implantable Device for Type 1 Diabetes Treatment
Elina Kadriu | Apr 18, 2023 | 3 min read
Engineering of a novel device to treat T1D, featuring local immunosuppression and a vascularized cell reservoir to prolong islet cell survival.
Histology showing IL-6 expression
Immune Molecule Alters Cellular Makeup of Human Brain Organoids
Charles Q. Choi, Spectrum | Apr 17, 2023 | 4 min read
The changes may help explain the link between maternal infection and autism, though more research is needed.
Learn how recombinant proteins move the diagnostic industry forward
Emergent Recombinant Proteins in Clinical Diagnostics
Scripps Laboratories | 1 min read
A new era of reliable recombinant proteins makes it possible for researchers to replace tissue-derived biomarkers in a variety of diagnostic assays.
Bladder epithelial tissue, where cell junctions are shown in green and nuclei in blue. This was grown in vitro from cells taken from mice with chronic cystitis.
Bladder ‘Memory’ Influences Urinary Tract Infection Recurrence in Mice
Alejandra Manjarrez, PhD | Apr 12, 2023 | 3 min read
Urinary tract infections leave permanent epigenetic marks in the mouse bladder epithelium, reprogramming its response to subsequent infections, a study finds.
Surface rendering of microscopy image showing two dendritic cells (green) communicating with a nociceptor neuron (violet).
How Cells in the Skin Team Up To Fight Pathogens
Rachael Moeller Gorman | Apr 12, 2023 | 4 min read
Immune cells and pain neurons form complex partnerships to protect our bodies from pathogens, new research reveals.
Learn about the latest research on optimal vaccine-induced immune responses
Modulating the Immune Response to Vaccines
The Scientist’s Creative Services Team | 1 min read
Researchers uncover innovative natural approaches to fine-tune immunity from vaccination.
Artist&rsquo;s rendering of bright orange <em >E. coli&nbsp;</em>bacteria
New Synthetic E. coli Is Immune to Bacteriophage Infection
Anna Napolitano, PhD | Mar 30, 2023 | 3 min read
Self-contained synthetic E. coli resistant to viral infection could prove invaluable to the biotechnology industry by increasing product consistency and reducing safety concerns. 
Artist&rsquo;s rendition of red SARS-CoV-2 coronaviruses floating near blue strands of DNA.
COVID-19 Infections May Reshape Genetic Landscape
Holly Barker, PhD | Mar 30, 2023 | 3 min read
SARS-CoV-2 infection triggers structural changes in the host cell’s DNA, which provide a molecular explanation for long COVID, a new study suggests. 
ADVERTISEMENT